{
  "Variants Include": [
    {
      "Gene": "α-Synuclein (SNCA)",
      "variants": [
        {
          "HGVS": "NM_000335291.3:c.A30P",
          "cDNA Change": {
            "transcript": "NM_000335291.3",
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Protein Change": {
            "ref": "Ala",
            "alt": "Pro",
            "position": "10"
          },
          "Description in input context": "A30P"
        },
        {
          "HGVS": "NM_000335291.3:c.E46K",
          "cDNA Change": {
            "transcript": "NM_000335291.3",
            "ref": "E",
            "alt": "K",
            "position": "46"
          },
          "Protein Change": {
            "ref": "Glu",
            "alt": "Lys",
            "position": "15"
          },
          "Description in input context": "E46K"
        },
        {
          "HGVS": "NM_000335291.3:c.A53T",
          "cDNA Change": {
            "transcript": "NM_000335291.3",
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Protein Change": {
            "ref": "Ala",
            "alt": "Thr",
            "position": "18"
          },
          "Description in input context": "A53T"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's Disease/Lewy Body Dementia (associated with SNCA mutations)",
    "MONDO": "MONDO:0005131"
  },
  "Experiment Method": [
    {
      "Assay Method": "In vitro studies, protein aggregation assays",
      "Material used": {
        "Material Source": "Recombinant protein, cell cultures",
        "Material Name": "N/A",
        "Description": "Recombinant α-synuclein protein was used in aggregation assays and expressed in cell cultures."
      },
      "Readout type": "Qualitative and Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000335291.3:c.A30P",
          "Conclusion": "N/A",
          "Molecular Effect": "Increased aggregation propensity",
          "Result Description": "The A30P variant demonstrated increased protein aggregation compared to wild-type."
        },
        {
          "Variant": "NM_000335291.3:c.E46K",
          "Conclusion": "N/A",
          "Molecular Effect": "Altered protein folding",
          "Result Description": "The E46K variant exhibited alterations in protein folding patterns."
        },
        {
          "Variant": "NM_000335291.3:c.A53T",
          "Conclusion": "N/A",
          "Molecular Effect": "Increased aggregation",
          "Result Description": "The A53T variant showed a tendency for increased protein aggregation."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Replicates were used in aggregation assays."
      },
      "Technical replicates": {
        "Technical replicates": "N/A",
        "Description": "Not specifically mentioned."
      },
      "Basic positive control": {
        "Basic positive control": "Wild-type α-synuclein",
        "Description": "Wild-type α-synuclein served as a control for comparison of aggregation."
      },
      "Basic negative control": {
        "Basic negative control": "N/A",
        "Description": "Not explicitly mentioned."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N/A",
        "Counts": "N/A"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N/A",
        "Counts": "N/A"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N/A (Qualitative observations)"
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N/A (Qualitative observations)",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N/A (Qualitative observations)",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "N/A"
      }
    }
  ]
}